☆ 4.3 Article

Comprehensive bioinformatics analysis reveals the oncogenic role of FoxM1 and its impact on prognosis, immune microenvironment, and drug sensitivity in osteosarcoma

JOURNAL OF APPLIED GENETICS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Immunology

Anoikis patterns exhibit distinct prognostic and immune landscapes in Osteosarcoma

Zhao Zhang et al.

Summary: This study explores the significance of anoikis-related genes (ANRGs) in osteosarcoma and their impact on the immune landscape. It establishes a prognostic signature based on ANRGs and develops a model for predicting survival probability in osteosarcoma patients. The study also identifies chemotherapeutic agents suitable for different subtypes of osteosarcoma.

INTERNATIONAL IMMUNOPHARMACOLOGY (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

Comprehensive analysis of hypoxia-related genes for prognosis value, immune status, and therapy in osteosarcoma patients

Tao Han et al.

Summary: This study aimed to establish a reliable risk prognostic model to predict the prognosis of osteosarcoma patients. Two molecular subgroups were identified, and a risk model based on 12 genes was developed. High-risk patients had poor prognosis, while low-risk patients had good prognosis. The model can assist clinicians in osteosarcoma prognosis management.

FRONTIERS IN PHARMACOLOGY (2023)

添加到收藏夹

Article Medicine, General & Internal

Integrated gene network analysis sheds light on understanding the progression of Osteosarcoma

Hrituraj Dey et al.

Summary: By analyzing gene-gene interaction networks, this study aimed to identify the hub genes involved in Osteosarcoma and understand their interaction and impact on various biological processes and signaling pathways. The research revealed several key genes such as TP53, CCND1, CDK4, STAT3, and VEGFA, which are associated with major signaling pathways in Osteosarcoma and have the potential to be targeted for drug development.

FRONTIERS IN MEDICINE (2023)

添加到收藏夹

Article Oncology

Integrative analysis of immune-related multi-omics profiles identifies distinct prognosis and tumor microenvironment patterns in osteosarcoma

Deyao Shi et al.

Summary: In this study, we investigated the potential association of alterations in DNA methylation and immune-related gene transcription with changes in the tumor microenvironment and prognosis of osteosarcoma (OS). We found that immune-related DNA methylation patterns have a significant impact on the prognosis and tumor microenvironment characteristics of OS.

MOLECULAR ONCOLOGY (2022)

添加到收藏夹

Article Biotechnology & Applied Microbiology

N6-methyladenosine methyltransferase WTAP-stabilized FOXD2-AS1 promotes the osteosarcoma progression through m6A/FOXM1 axis

Zhipeng Ren et al.

Summary: This study reveals the critical role of m(6)A-modified lncRNA FOXD2-AS1 in osteosarcoma progression, by enhancing the stability of FOXD2-AS1 transcripts and forming a complex with FOXM1 mRNA, thereby promoting migration, proliferation, and tumor growth.

BIOENGINEERED (2022)

添加到收藏夹

Article Immunology

Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma

Fangxing Xu et al.

Summary: In this study, a gene signature related to glycolysis and cholesterol synthesis was constructed to predict the prognosis and guide therapy for osteosarcoma patients.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Orthopedics

Circ-FOXM1 promotes the proliferation, migration and EMT process of osteosarcoma cells through FOXM1-mediated Wnt pathway activation

Hao Zhang et al.

Summary: The study found that circ-FOXM1 promotes malignant phenotypes of OS cells by activating the FOXM1-mediated Wnt pathway. Therefore, circ-FOXM1 may serve as a potential biomarker for OS treatment.

JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2022)

添加到收藏夹

Article Immunology

A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA

Mingyi Yang et al.

Summary: This study identified CRLncs that can guide OS prognosis and the immune microenvironment, as well as drugs with potential efficacy for OS, providing a theoretical basis for OS survival research and clinical decision-making.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Immunology

The hexosamine biosynthesis pathway-related gene signature correlates with immune infiltration and predicts prognosis of patients with osteosarcoma

Zexin Su et al.

Summary: By comprehensively assessing the metabolic characteristics of osteosarcoma patients, we constructed a risk score model based on the hexosamine biosynthesis pathway (HBP) to predict the prognosis and tumor immune infiltration in patients with osteosarcoma. This model can guide immunotherapy and targeted therapy for osteosarcoma.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Immunology

Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis

Yigang Lv et al.

Summary: This study investigates the role of aging-/senescence-induced genes (ASIGs) in osteosarcoma diagnosis, prognosis, and therapeutic agent prediction. Different molecular subgroups of osteosarcoma based on ASIGs were identified, and their immune landscape and prognosis were predicted using a novel aging-associated gene signature risk score. The study also explores the correlation between the risk score and the tumor immune microenvironment, providing insights for immunotherapy and chemotherapy in osteosarcoma.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Immunology

A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy

Runsang Pan et al.

Summary: This study constructed a risk model to predict the prognosis and guide therapeutic strategies for osteosarcoma (OS) by analyzing gene expression profiles and immune cell infiltration.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Cell Biology

The hypoxia-related signature predicts prognosis, pyroptosis and drug sensitivity of osteosarcoma

Lin Hu et al.

Summary: This study investigates the relationship between hypoxia, pyroptosis, tumor immune microenvironment, chemosensitivity, and prognosis in osteosarcoma. The findings suggest that hypoxia can influence the tumor immune microenvironment and promote pyroptosis, leading to poor prognosis and low chemosensitivity. The study also develops hypoxia and pyroptosis risk models based on gene data and clinical data, which can predict the prognosis and chemotherapy sensitivities of osteosarcoma patients.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

添加到收藏夹

Article Oncology

Evaluation of the Chemotherapy Drug Response Using Organotypic Cultures of Osteosarcoma Tumours from Mice Models and Canine Patients

Benedicte Brulin et al.

Summary: The study highlights the importance of replicating the 3D tumor microenvironment to better predict drug response and provides evidence for the utility and possibilities of organotypic culture for enhanced preclinical selection and evaluation of chemotherapeutics targeting osteosarcoma.

CANCERS (2021)

添加到收藏夹

Article Oncology

The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma

Lijiang He et al.

Summary: This study developed a novel predictive signature for chemotherapy response in osteosarcoma patients by analyzing immune cell infiltration and gene expression profiles. High-level immune infiltration was associated with good responders, and a panel of five IRGs was identified as predictive for chemotherapy response. The predictive signature showed accuracy of 0.832 for the training cohort and 0.720 for the validation cohort, suggesting its potential for improving chemotherapy efficacy in osteosarcoma patients.

BMC CANCER (2021)

添加到收藏夹

Article Oncology

Targeting the CtBP1-FOXM1 transcriptional complex with small molecules to overcome MDR1-mediated chemoresistance in osteosarcoma cancer stem cells

Xun Chen et al.

Summary: The study identified that the CtBP1-FOXM1 complex activates MDR1 expression in cisplatin-resistant osteosarcoma cancer stem cells, leading to chemoresistance. Targeting this complex with specific inhibitors can reverse MDR1-mediated chemoresistance, offering a new therapeutic strategy for overcoming chemoresistance during osteosarcoma treatment.

JOURNAL OF CANCER (2021)

添加到收藏夹

Article Oncology

Cadmium chloride enhances cisplatin sensitivity in osteosarcoma cells by reducing FOXM1 expression

Konghe Hu et al.

ONCOLOGY REPORTS (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

SPAG5 promotes osteosarcoma metastasis via activation of FOXM1/MMP2 axis

Zhiyun Li et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2020)

添加到收藏夹

Article Oncology

FoxM1 is Upregulated in Osteosarcoma and Inhibition of FoxM1 Decreases Osteosarcoma Cell Proliferation, Migration, and Invasion

Xia Zhu et al.

CANCER MANAGEMENT AND RESEARCH (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Replication stress and FOXM1 drive radiation induced genomic instability and cell transformation

Zhentian Li et al.

PLOS ONE (2020)

添加到收藏夹

Article Oncology

Thiostrepton and miR-216b synergistically promote osteosarcoma cell cytotoxicity and apoptosis by targeting FoxM1

Xiaobing Cai et al.

ONCOLOGY LETTERS (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

SIAH1/ZEB1/IL-6 axis is involved in doxorubicin (Dox) resistance of osteosarcoma cells

Xiuxin Han et al.

BIOLOGICAL CHEMISTRY (2019)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Avasimibe inhibits tumor growth by targeting FoxM1-AKR1C1 in osteosarcoma

Liang Wang et al.

ONCOTARGETS AND THERAPY (2019)

添加到收藏夹

Article Oncology

Long noncoding RNA MIR31HG abrogates the availability of tumor suppressor microRNA-361 for the growth of osteosarcoma

Yongjie Sun et al.

CANCER MANAGEMENT AND RESEARCH (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Diallyl disulfide suppresses FOXM1-mediated proliferation and invasion in osteosarcoma by upregulating miR-134

Yonggang Li et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

MiR-216b inhibits osteosarcoma cell proliferation, migration, and invasion by targeting Forkhead Box M1

Wei Wang et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2019)

添加到收藏夹

Article Cell Biology

LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1

Bin Shen et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

添加到收藏夹

Article Oncology

Targeting the FOXM1-regulated long noncoding RNA TUG1 in osteosarcoma

Yang Li et al.

CANCER SCIENCE (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Oncogenic role of SFRP2 in p53-mutant osteosarcoma development via autocrine and paracrine mechanism

Huensuk Kim et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

添加到收藏夹

Article Oncology

Abemaciclib Is Active in Preclinical Models of Ewing Sarcoma via Multipronged Regulation of Cell Cycle, DNA Methylation, and Interferon Pathway Signaling

Michele Dowless et al.

CLINICAL CANCER RESEARCH (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

DNA Methylation Mediated Down-Regulation of miR-370 Regulates Cell Growth through Activation of the Wnt/β-Catenin Signaling Pathway in Human Osteosarcoma Cells

Wentao Zhang et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.